A detailed history of Aqr Capital Management LLC transactions in Charles River Laboratories International, Inc. stock. As of the latest transaction made, Aqr Capital Management LLC holds 44,627 shares of CRL stock, worth $8.29 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
44,627
Previous 62,253 28.31%
Holding current value
$8.29 Million
Previous $12.9 Million 31.64%
% of portfolio
0.01%
Previous 0.02%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$187.96 - $245.29 $3.31 Million - $4.32 Million
-17,626 Reduced 28.31%
44,627 $8.79 Million
Q2 2024

Aug 14, 2024

BUY
$206.39 - $268.73 $4.38 Million - $5.71 Million
21,235 Added 51.77%
62,253 $12.9 Million
Q1 2024

May 15, 2024

SELL
$203.52 - $273.43 $6.5 Million - $8.74 Million
-31,955 Reduced 43.79%
41,018 $11.1 Million
Q4 2023

Feb 14, 2024

SELL
$164.52 - $238.84 $1.92 Million - $2.78 Million
-11,643 Reduced 13.76%
72,973 $17.3 Million
Q3 2023

Nov 14, 2023

BUY
$194.44 - $217.61 $3.76 Million - $4.21 Million
19,347 Added 29.64%
84,616 $16.6 Million
Q2 2023

Aug 14, 2023

SELL
$183.71 - $210.25 $1.07 Million - $1.22 Million
-5,812 Reduced 8.18%
65,269 $13.7 Million
Q1 2023

May 15, 2023

BUY
$191.89 - $259.92 $2.79 Million - $3.78 Million
14,524 Added 25.68%
71,081 $14.3 Million
Q4 2022

Feb 14, 2023

SELL
$197.11 - $250.07 $10.5 Million - $13.4 Million
-53,472 Reduced 48.6%
56,557 $12.3 Million
Q3 2022

Nov 14, 2022

SELL
$182.44 - $250.54 $12.8 Million - $17.6 Million
-70,368 Reduced 39.01%
110,029 $21.7 Million
Q2 2022

Aug 15, 2022

BUY
$204.13 - $302.4 $12.1 Million - $17.9 Million
59,131 Added 48.76%
180,397 $38.6 Million
Q1 2022

May 16, 2022

BUY
$255.51 - $362.11 $10.3 Million - $14.6 Million
40,193 Added 49.58%
121,266 $34.4 Million
Q4 2021

Feb 14, 2022

SELL
$351.38 - $448.68 $2.35 Million - $3.01 Million
-6,700 Reduced 7.63%
81,073 $30.5 Million
Q3 2021

Nov 15, 2021

SELL
$372.64 - $458.3 $1.21 Million - $1.49 Million
-3,245 Reduced 3.57%
87,773 $36.2 Million
Q2 2021

Aug 16, 2021

SELL
$294.17 - $371.65 $23.4 Million - $29.6 Million
-79,665 Reduced 46.67%
91,018 $33.6 Million
Q1 2021

May 17, 2021

SELL
$249.67 - $299.48 $21.2 Million - $25.4 Million
-84,835 Reduced 33.2%
170,683 $49.5 Million
Q4 2020

Feb 16, 2021

SELL
$222.0 - $252.62 $33.6 Million - $38.2 Million
-151,236 Reduced 37.18%
255,518 $62.9 Million
Q3 2020

Nov 16, 2020

SELL
$175.56 - $226.45 $55.6 Million - $71.8 Million
-316,950 Reduced 43.8%
406,754 $90.9 Million
Q2 2020

Aug 17, 2020

SELL
$118.84 - $189.72 $75.1 Million - $120 Million
-631,701 Reduced 46.61%
723,704 $123 Million
Q1 2020

May 15, 2020

SELL
$98.9 - $178.34 $31.3 Million - $56.5 Million
-316,752 Reduced 18.94%
1,355,405 $171 Million
Q4 2019

Feb 14, 2020

SELL
$126.05 - $152.76 $42.2 Million - $51.1 Million
-334,771 Reduced 16.68%
1,672,157 $255 Million
Q3 2019

Nov 14, 2019

SELL
$125.07 - $143.67 $29.1 Million - $33.5 Million
-232,993 Reduced 10.4%
2,006,928 $266 Million
Q2 2019

Aug 14, 2019

BUY
$123.4 - $148.55 $19.4 Million - $23.3 Million
157,160 Added 7.55%
2,239,921 $318 Million
Q1 2019

May 14, 2019

BUY
$104.82 - $146.73 $33.2 Million - $46.5 Million
317,001 Added 17.95%
2,082,761 $301 Million
Q4 2018

Feb 14, 2019

BUY
$105.09 - $137.23 $15.4 Million - $20.1 Million
146,201 Added 9.03%
1,765,760 $200 Million
Q3 2018

Nov 15, 2018

SELL
$112.11 - $134.54 $541,267 - $649,559
-4,828 Reduced 0.3%
1,619,559 $218 Million
Q2 2018

Aug 14, 2018

BUY
$102.37 - $117.25 $9.88 Million - $11.3 Million
96,522 Added 6.32%
1,624,387 $182 Million
Q1 2018

May 15, 2018

BUY
$98.19 - $115.2 $449,513 - $527,385
4,578 Added 0.3%
1,527,865 $163 Million
Q4 2017

Feb 14, 2018

BUY
$100.43 - $118.09 $1.1 Million - $1.29 Million
10,906 Added 0.72%
1,523,287 $167 Million
Q3 2017

Nov 14, 2017

BUY
$96.72 - $109.26 $146 Million - $165 Million
1,512,381
1,512,381 $163 Million

Others Institutions Holding CRL

About CHARLES RIVER LABORATORIES INTERNATIONAL, INC.


  • Ticker CRL
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 50,863,300
  • Market Cap $9.45B
  • Description
  • Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...
More about CRL
Track This Portfolio

Track Aqr Capital Management LLC Portfolio

Follow Aqr Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Aqr Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Aqr Capital Management LLC with notifications on news.